FMC

FMC Corp

Add to Watchlist

Advanced Chart

41.330

-0.74(-1.759%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

42.135

Open

41.860

VWAP

Vol

3.25M

Mkt Cap

5.16B

Low

40.680

Amount

EV/EBITDA(TTM)

11.59

Total Shares

124.82M

8.97B

EV/OCF(TTM)

26.82

P/S(TTM)

1.28

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

1.31B

+7.34%

1.802

+0.69%

1.09B

+2.7%

0.852

+23.49%

995.15M

-4.16%

0.621

-1.49%

Estimates Revision

The market is revising Upward the revenue expectations for FMC Corporation (FMC) for FY2025, with the revenue forecasts being adjusted by 0.52% over the past three months. During the same period, the stock price has changed by -1.41%.

Revenue Estimates for FY2025

Revise Upward

+0.52%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.24%

In Past 3 Month

Stock Price

Go Down

-1.41%

In Past 3 Month

13 Analyst Rating

13.07% Upside

Wall Street analysts forecast FMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMC is 46.73 USD with a low forecast of 34.00 USD and a high forecast of 53.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

6 Hold

1 Sell

Moderate Buy

13.07% Upside

Current: 41.330

Low

34.00

Averages

46.73

High

53.00

13.07% Upside

Current: 41.330

Low

34.00

Averages

46.73

High

53.00

RBC Capital

Sector Perform

maintain

$40 -> $47

2025-07-10

Reason

RBC Capital

Price Target

$40 -> $47

2025-07-10

maintain

Sector Perform

Reason

RBC Capital raised the firm's price target on FMC to $47 from $40 and keeps a Sector Perform rating on the shares as part of a broader research note on Ag Chemicals. The firm has updated its crop yield forecast model after the April WASDE report, maintaining its belief that Ag fundamentals are improving given lower Soybean stocks/use, with WASDE still expecting farmer income to improve nearly 30% in 2025 vs 2024 given higher government payments, the analyst tells investors in a research note. Price-to-cost should be flat to positive for the company given new product offerings, cost deflation, self-help and recent Fluindapyr sales collaborations, RBC added.

UBS

Joshua Spector

Neutral

maintain

$41 -> $45

2025-07-09

Reason

UBS

Joshua Spector

Price Target

$41 -> $45

2025-07-09

maintain

Neutral

Reason

UBS analyst Joshua Spector raised the firm's price target on FMC to $45 from $41 and keeps a Neutral rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.

Barclays

Overweight

maintain

$48 -> $49

2025-07-07

Reason

Barclays

Price Target

$48 -> $49

2025-07-07

maintain

Overweight

Reason

Barclays raised the firm's price target on FMC to $49 from $48 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the Americas agribusiness group. The firm adjusted price targets on better fertilizer pricing and strong North America sees volumes. Demand has remained strong despite high fertilizer prices, the analyst tells investors in a research note.

Wells Fargo

Equal Weight -> Overweight

upgrade

$41 -> $50

2025-06-23

Reason

Wells Fargo

Price Target

$41 -> $50

2025-06-23

upgrade

Equal Weight -> Overweight

Reason

Wells Fargo upgraded FMC to Overweight from Equal Weight with a price target of $50, up from $41.

Wells Fargo

Equal Weight -> Overweight

upgrade

$41 -> $50

2025-06-23

Reason

Wells Fargo

Price Target

$41 -> $50

2025-06-23

upgrade

Equal Weight -> Overweight

Reason

Wells Fargo upgraded FMC (FMC) to Overweight from Equal Weight with a price target of $50, up from $41. The firm is "increasingly confident" that 2024 will mark the near-term bottom for FMC's earnings given positive market trends and strategic actions. The company will be able to meet its 2025 earnings guidance, with a return to the double-digit earnings growth algorithm in 2026, the analyst tells investors in a research note. Wells views the recently announced strategic partnerships with Bayer and Corteva (CTVA) as positive drivers of demand for FMC's new active ingredients. The deals bring validation to the technology and support faster penetration of new markets for FMC in 2026 and beyond, contends Wells.

Mizuho

Neutral -> Outperform

upgrade

$46 -> $49

2025-04-25

Reason

Mizuho

Price Target

$46 -> $49

2025-04-25

upgrade

Neutral -> Outperform

Reason

Mizuho upgraded FMC to Outperform from Neutral with a price target of $49, up from $46. FMC trades at 8.5-times consensus next 12 months EBITDA, near the lowest multiple since the company's transformation in 2017, the analyst tells investors in a research note. At the current valuation, the firm believes downside is limited and sees the stock's risk/reward as attractive. The challenges facing FMC are well-known and mostly priced in, contends Mizuho. It believes investor focus should and will soon shift to the company's medium- and longer-term opportunities, driven by new products that will deliver value.

See All Ratings

Valuation Metrics

The current forward P/E ratio for FMC Corp (FMC.N) is 11.27, compared to its 5-year average forward P/E of 16.03. For a more detailed relative valuation and DCF analysis to assess FMC Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

16.03

Current PE

11.27

Overvalued PE

20.57

Undervalued PE

11.48

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

12.26

Current EV/EBITDA

9.65

Overvalued EV/EBITDA

14.31

Undervalued EV/EBITDA

10.21

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

2.28

Current PS

1.24

Overvalued PS

2.92

Undervalued PS

1.63